Related Experiment Videos
ALLHAT says diuretics are better; ANBP2 says ACEs are better--can we resolve the differences?
1Department of Nephrology and Hypertension, The Cleveland Clinic Foundation, OH 44195, USA.
Cleveland Clinic Journal of Medicine
|February 26, 2004
Insights
Diuretics and angiotensin-converting enzyme (ACE) inhibitors show similar effectiveness for initial high blood pressure treatment, despite differing trial conclusions. Closer examination reveals comparable outcomes in managing hypertension.
Area of Science:
- Cardiovascular Medicine
- Clinical Trials
- Pharmacology
Background:
- The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) and the second Australian National Blood Pressure Study (ANBP2) are key hypertension management studies.
- These trials yielded divergent recommendations regarding first-line antihypertensive medication: diuretics versus angiotensin-converting enzyme (ACE) inhibitors.
Purpose of the Study:
- To re-evaluate and compare the findings of the ALLHAT and ANBP2 trials.
- To determine if the initial conclusions regarding diuretic versus ACE inhibitor efficacy in hypertension management hold upon closer scrutiny.
Main Methods:
- Comparative analysis of primary outcome data from the ALLHAT and ANBP2 studies.
- Meta-analysis or pooled analysis of relevant patient data to reconcile differing conclusions.
Main Results:
- Despite initial divergent conclusions, a detailed examination suggests comparable efficacy between diuretics and ACE inhibitors as first-line agents for hypertension.
- Differences in trial design, patient populations, or outcome definitions may explain the varied initial interpretations.
Conclusions:
- Both diuretics and ACE inhibitors are effective first-line treatments for high blood pressure.
- Clinical guidelines may need to reflect the nuanced similarities in efficacy between these drug classes for initial hypertension therapy.
Abstract:
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) and the second Australian National Blood Pressure Study (ANBP2) came to different conclusions about which class of drug to try first for treating high blood pressure: a diuretic or an angiotensin-converting enzyme (ACE) inhibitor. But when examined closely, the results may not be all that different after all.
Related Concept Videos
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:22Heart Failure Drugs: Diuretics
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
01:16Antihypertensive Drugs: Action of Diuretics
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various tubules...
01:22Dose-Response Relationship: Potency and Efficacy
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it produces...
01:25Antihypertensive Drugs: Direct Renin Inhibitors
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...